Celestica remains a 'Buy' as recent consolidation offers an attractive entry, with valuation multiples compressing despite ...
TD Cowen 46th Annual Health Care Conference March 3, 2026 9:50 AM ESTCompany ParticipantsMike Brophy - Chief Financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results